Grifols | GRFS - Trade Creditors


Grifols reported EUR1.04B in Trade Creditors for its fiscal quarter ending in June of 2025.





Trade Creditors Change Date
Alaunos Therapeutics USD 843K 34K Sep/2025
Arca Biopharma USD 4.36M 5.12M Mar/2025
aTyr Pharma USD 4.06M 184K Sep/2025
Bio Path USD 3.48M 1.14M Jun/2025
Brainstorm Cell Therapeutics USD 6.42M 423K Sep/2025
Capricor Therapeutics 2.72M 2.09M Sep/2025
Cara Therapeutics USD 2.42M 2.42M Jun/2025
Esperion Therapeutics USD 77.51M 2.81M Sep/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
Grifols EUR 1.04B 183.31M Jun/2025
Immunic USD 7.92M 25K Sep/2025
Infinity Pharmaceuticals USD 1.5M 433K Jun/2023
Minerva Neurosciences USD 945K 48K Sep/2025
Nektar Therapeutics USD 15.56M 1.28M Sep/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
TherapeuticsMD USD 143K 4K Jun/2024